CTRI/2023/12/060577已完成2 期
To evaluate the efficacy of the test product in comparison to baseline in improving hair growth rate and hair fall reduction in healthy female subjects
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 38
- 试验地点
- 1
- 主要终点
- assessment of reduction in hair fall, hair growth rate, hair density, thickness
研究概览
简要总结
Adult female subjects with age between 18-45 years (both inclusive) will be screened for eligibility criteria. On screening visit, before starting any study procedure, written informed consent will be obtained.
All baseline assessment like baseline dermatological assessments and imaging will be performed. Post baseline assessments, the selected subjects will be provided with the test product. The subjects will be instructed to use the test product for 90/92 days.
Follow up evaluations will be performed at day 14 & 16, day 30 & 32, day 60 and 62 and day 90 & 92.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Female subjects in general good health. 2)Subjects in the age group 18-45 years (both the ages inclusive). 3)Subjects complaining of hair fall and damage. 4)Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5)Hair density of >100 and <200 hair follicle per square cm as per Trichoscan measurement 6)Female subjects falling under Grade
- •Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In use Scale).
排除标准
- •Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •Subjects having any active scalp disease which may interfere in the study – dermatologist’s judgement.
- •Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania.
- •Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex.
- •phenytoin) and finasteride for androgenic alopecia, under medical treatment for hair problems.
- •A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / colour/ henna which will compromise the study.
- •Subjects with chronic illness which may influence the cutaneous state.
- •Subjects participating in other similar cosmetic or therapeutic trial within last three months.
- •Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
结局指标
主要结局
assessment of reduction in hair fall, hair growth rate, hair density, thickness
时间窗: Day 1, 14, 30 , 60 and 90
次要结局
- NA(NA)
研究者
Dr Mukesh Ramnane
MS Clinical Research Pvt Ltd
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
Study to assess hair growthCTRI/2024/03/064879AVT Natural Products Limited45
已完成
2 期
Grey hair study on male and female subjects for a period of 4 monthsOther hair color and hair shaft abnormalities. Ayurveda Condition: AKALAPALITAHÂ (KEVALAPITTA),CTRI/2024/10/074760Hindustan Unilever Ltd45
尚未招募
不适用
A study to evaluate the effectiveness of the test product in improving scalp health over a period of 4 weeks.CTRI/2025/03/082878LiquidCubes InnoCommerce (LiquidCubes)90
已完成
不适用
Hydration studyCTRI/2024/12/077872ITC Life Sciences & Technology Centre,40
已完成
3 期
Clotrimazole treatment in vaginal fungal InfectionsCTRI/2024/05/068227Miltonia Health Science Ltd60